von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005;23(21):4602–8.
Felsenstein KM, Theodorescu D. Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy. Nat Rev Urol. 2017; nrurol. 2017.2179.
Lima LG, Monteiro RQ. Activation of blood coagulation in cancer: implications for tumour progression. Biosci Rep. 2013;33(5):e00064.
Article
CAS
PubMed
PubMed Central
Google Scholar
Young A, Chapman O, Connor C, Poole C, Rose P, Kakkar AK. Thrombosis and cancer. Nat Rev Clin Oncol. 2012;9(8):437–49.
Kalagara T, Moutsis T, Yang Y, Pappelbaum KI, Farken A, Cladder-Micus L, et al. The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium. Blood Adv. 2018;2(18):2347–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bauer AT, Suckau J, Frank K, Desch A, Goertz L, Wagner AH, et al. von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans. Blood. 2015;125(20):3153–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang X, Wang E, Kavanagh JJ, Freedman RS. Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med. 2005;3(1):25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Caldwell JA, Dickhout JG, Al-Hashimi AA, Austin RC. Development of a continuous assay for the measurement of tissue factor procoagulant activity on intact cells. Lab Investig. 2010;90(6):953–62.
Article
CAS
PubMed
Google Scholar
Voigtlaender M, Holstein K, Leuenroth S, Mudter J, Bokemeyer C, Langer F. Clinical evidence that coagulation activation drives Cancer progression-a report of 2 cases. Oncol Res treatment. 2015;38(9):449–52.
Article
Google Scholar
Patry G, Hovington H, Larue H, Harel F, Fradet Y, Lacombe L. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer. Int J Cancer. 2008;122(7):1592–7.
Article
CAS
PubMed
Google Scholar
Chen M-F, Lin P-Y, Wu C-F, Chen W-C, Wu C-T. IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One. 2013;8(4):e61901.
Article
CAS
PubMed
PubMed Central
Google Scholar
Andrews B, Shariat SF, Kim J-H, Wheeler TM, Slawin KM, Lerner SP. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol. 2002;167(3):1475–81.
Article
PubMed
Google Scholar
Strozyk EA, Desch A, Poeppelmann B, Magnolo N, Wegener J, Huck V, et al. Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NF kappa B activation. Exp Dermatol. 2014;23(9):670–6.
Article
CAS
PubMed
Google Scholar
Li YY, Chung GT, Lui VW, To K-F, Ma BB, Chow C, et al. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations. Nat Commun. 2017;8:14121.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vidal-Vanaclocha F, Fantuzzi G, Mendoza L, Fuentes AM, Anasagasti MJ, Martín J, et al. IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci. 2000;97(2):734–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mukherjee N, Houston TJ, Cardenas E, Ghosh R. To be an ally or an adversary in bladder cancer: the NF-κB story has not unfolded. Carcinogenesis. 2014;36(3):299–306.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deng Q-F, Sun X, Liang Z-F, Zhang Z-Q, Yu D-X, Zhong C-Y. Cigarette smoke extract induces the proliferation of normal human urothelial cells through the NF-κB pathway. Oncol Rep. 2016;35(5):2665–72.
Article
CAS
PubMed
Google Scholar
Sun Y, Guan Z, Liang L, Cheng Y, Zhou J, Li J, et al. NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression. Int J Oncol. 2016;48(1):225–34.
Article
CAS
PubMed
Google Scholar
Klemke M, Weschenfelder T, Konstandin MH, Samstag Y. High affinity interaction of integrin α4β1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J Cell Physiol. 2007;212(2):368–74.
Article
CAS
PubMed
Google Scholar
Petzoldt JL, Leigh IM, Duffy PG, Sexton C, Masters JRW. Immortalisation of human urothelial cells. Urol Res. 1995;23(6):377–80.
Article
CAS
PubMed
Google Scholar
Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Keese CR, Bhawe K, Wegener J, Giaever I. Real-time impedance assay to follow the invasive activities of metastatic cells in culture. Biotechniques. 2002;33(4):842.
Article
CAS
PubMed
Google Scholar
Kulig P, Burkhard S, Mikita-Geoffroy J, Croxford AL, Hovelmeyer N, Gyulveszi G, et al. IL17A-mediated endothelial breach promotes metastasis formation. Cancer Immunol Res. 2016;4(1):26–32.
Article
CAS
PubMed
Google Scholar
Pappelbaum KI, Gorzelanny C, Grassle S, Suckau J, Laschke MW, Bischoff M, et al. Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress. Circulation. 2013;128(1):50–9.
Article
CAS
PubMed
Google Scholar
Baeuerle PA, Baichwal VR. NF-kB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997;65:111–38.
Article
CAS
PubMed
Google Scholar
John A, Robador JR, Vidal YSS, Houdek P, Wladykowski E, Gunes C et al. Urothelial Carcinoma of the Bladder Induces Endothelial Cell Activation and Hypercoagulation. Mol Cancer Res. 2020;18(7):1099–109.
Witjes JA, Bruins M, Compérat E, Cowan NC, Gakis G, Hernández V, et al. EAU guidelines on muscle-invasive and metastatic bladder Cancer 2018. In: European Association of Urology guidelines 2018 edition. Volume presented at the EAU annual congress Copenhagen 2018, edn. Arnhem: European Association of Urology Guidelines Office; 2018.
Google Scholar
Shenoy AK, Lu J. Cancer cells remodel themselves and vasculature to overcome the endothelial barrier. Cancer Lett. 2016;380(2):534–44.
Article
CAS
PubMed
Google Scholar
Blazejczyk A, Papiernik D, Porshneva K, Sadowska J, Wietrzyk J. Endothelium and cancer metastasis: perspectives for antimetastatic therapy. Pharmacol Rep. 2015;67(4):711–8.
Article
CAS
PubMed
Google Scholar
Geng J-G. Interaction of vascular endothelial cells with leukocytes, platelets and cancer cells in inflammation, thrombosis and cancer growth and metastasis. Acta Pharmacol Sin. 2003;24(12):1297–300.
CAS
PubMed
Google Scholar
Stegner D, Dütting S, Nieswandt B. Mechanistic explanation for platelet contribution to cancer metastasis. Thromb Res. 2014;133:S149–57.
Article
CAS
PubMed
Google Scholar
Tao L, Qiu J, Slavin S, Ou Z, Liu Z, Ge J, et al. Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor beta/IL-1/c-MET signals. Cancer Lett. 2018;430:215–23.
Article
CAS
PubMed
Google Scholar
Grimm S, Jennek S, Singh R, Enkelmann A, Junker K, Rippaus N, et al. Malignancy of bladder cancer cells is enhanced by tumor-associated fibroblasts through a multifaceted cytokine-chemokine loop. Exp Cell Res. 2015;335(1):1–11.
Article
CAS
PubMed
Google Scholar
Miyake M, Hori S, Morizawa Y, Tatsumi Y, Nakai Y, Anai S, et al. CXCL1-mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer. Neoplasia. 2016;18(10):636–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tao L, Qiu J, Jiang M, Song W, Yeh S, Yu H et al. Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1-->Androgen Receptor-->HIF1alpha-->VEGFa Signals. Mol Cancer Ther. 2016;15(8):1943–51.
Reis ST, Leite KRM, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder Cancer. BMC Urol. 2012;12(1):18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ou Z, Wang Y, Liu L, Li L, Yeh S, Qi L, et al. Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals. Oncotarget. 2015;6(28):26065.
Article
PubMed
PubMed Central
Google Scholar
Becker M, Szarvas T, Wittschier M, Vom Dorp F, Tötsch M, Schmid KW, et al. Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer. Cancer. 2010;116(19):4502–12.
Article
CAS
PubMed
Google Scholar
Masson-Lecomte A, Rava M, Real FX, Hartmann A, Allory Y, Malats N. Inflammatory biomarkers and bladder cancer prognosis: a systematic review. Eur Urol. 2014;66(6):1078–91.
Article
CAS
PubMed
Google Scholar
Kinnunen K, Piippo N, Loukovaara S, Hytti M, Kaarniranta K, Kauppinen A. Lysosomal destabilization activates the NLRP3 inflammasome in human umbilical vein endothelial cells (HUVECs). J Cell Commun Signal. 2017;11(3):275–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miyake M, Furuya H, Onishi S, Hokutan K, Anai S, Chan O, et al. Monoclonal antibody against CXCL1 (HL2401) as a novel agent in suppressing IL6 expression and Tumoral growth. Theranostics. 2019;9(3):853–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miyake M, Goodison S, Urquidi V, Gomes Giacoia E, Rosser CJ. Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways. Lab Investig. 2013;93(7):768–78.
Article
CAS
PubMed
Google Scholar
Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci U S A. 2020;117(36):22351–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lo CW, Chen MW, Hsiao M, Wang S, Chen CA, Hsiao SM, et al. IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res. 2011;71(2):424–34.
Article
CAS
PubMed
Google Scholar
Alfaro C, Sanmamed MF, Rodriguez-Ruiz ME, Teijeira A, Onate C, Gonzalez A, et al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev. 2017;60:24–31.
Article
CAS
PubMed
Google Scholar
Wu C-T, Chang Y-H, Lin P-Y, Chen W-C, Chen M-F. Thrombomodulin expression regulates tumorigenesis in bladder cancer. BMC Cancer. 2014;14(1):375.
Article
CAS
PubMed
PubMed Central
Google Scholar
Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, Van Roy F, et al. Activation of NF-κB by Akt upregulates snail expression and induces epithelium mesenchyme transition. Oncogene. 2007;26(53):7445.
Article
CAS
PubMed
Google Scholar
Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, et al. Nuclear factor-κB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin Cancer Res. 2003;9(7):2786–97.
CAS
PubMed
Google Scholar
Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34(2):181–7.
Article
CAS
PubMed
Google Scholar
Mezouar S, Frère C, Darbousset R, Mege D, Crescence L, Dignat-George F, et al. Role of platelets in cancer and cancer-associated thrombosis: experimental and clinical evidences. Thromb Res. 2016;139:65–76.
Article
CAS
PubMed
Google Scholar
Worst TS, Reiner V, Gabriel U, Weiss C, Erben P, Martini T et al. IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status. Adv Urol. 2014:184602.
Sims JE, Pan Y, Smith DE, Nicklin MJ, Barton JL, Bazan JF, et al. A new nomenclature for IL-1-family genes. Trends Immunol. 2001;22(10):536–7.
Article
CAS
PubMed
Google Scholar
Dinarello CA. An expanding role for interleukin-1 blockade from gout to cancer. Mol Med. 2014;20(Suppl 1):S43–58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsumoto R, Tsuda M, Yoshida K, Tanino M, Kimura T, Nishihara H, et al. Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells. Sci Rep. 2016;6:34625.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ahirwar DK, Agrahari A, Mandhani A, Mittal RD. Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers. 2009;14(4):213–8.
Article
CAS
PubMed
Google Scholar
Bozdoğan S, Erol B, Dursun A, Bozdoğan G, Dönmez I, Mungan N, et al. The IL-1RN and IL-4 gene polymorphisms are potential genetic markers of susceptibility to bladder cancer: a case–control study. World J Urol. 2015;33(3):389–95.
Article
CAS
PubMed
Google Scholar
Leite CAVG, Alencar VTL, Melo DLR, Mota JMSC, Melo PH, Mourao LTC, et al. Target inhibition of IL-1 receptor prevents Ifosfamide induced hemorrhagic cystitis in mice. J Urology. 2015;194(6):1777–86.
Article
CAS
Google Scholar